These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10780333)

  • 1. Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with type III von Willebrand's disease and alloantibodies against von Willebrand factor.
    Grossmann RE; Geisen U; Schwender S; Keller F
    Thromb Haemost; 2000 Apr; 83(4):633-4. PubMed ID: 10780333
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of a hemorrhagic syndrome in severe von Willebrand disease in the presence of circulating anti-von-Willebrand-factor antibody].
    Monteagudo J; López Guillermo A; Castillo R
    Med Clin (Barc); 1988 May; 91(1):28-30. PubMed ID: 3139944
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired haemophilia in association with type III von Willebrand's disease: successful treatment with high purity von Willebrand's factor and recombinant factor VIIa.
    Majumdar G; Phillips JK; Lavallee H; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1035-7. PubMed ID: 8148477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor.
    Ciavarella N; Schiavoni M; Valenzano E; Mangini F; Inchingolo F
    Haemostasis; 1996; 26 Suppl 1():150-4. PubMed ID: 8904191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor.
    Bergamaschini L; Mannucci PM; Federici AB; Coppola R; Guzzoni S; Agostoni A
    J Lab Clin Med; 1995 Mar; 125(3):348-55. PubMed ID: 7897302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease.
    Friederich PW; Wever PC; Briët E; Doorenbos CJ; Levi M
    Am J Hematol; 2001 Apr; 66(4):292-4. PubMed ID: 11279642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of pregnancy in type 3 von Willebrand disease with alloantibodies.
    Scott M; Hay CRM; Elkhalifa S; Tower C; Cocker M; Thachil J
    Br J Haematol; 2018 Aug; 182(3):440-442. PubMed ID: 28699647
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of hemorrhage and elimination of immune inhibitors in a female patient with a severe form of von Willebrand's disease.
    Marisavljević D; Elezović I; Miljić P; Radulović M; Stajić M
    Srp Arh Celok Lek; 1997; 125(9-10):311-6. PubMed ID: 9340805
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of von Willebrand's disease.
    Logan LJ
    Prog Clin Biol Res; 1990; 324():279-90. PubMed ID: 2106690
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease.
    Mannucci PM; Mari D
    Prog Clin Biol Res; 1984; 150():109-22. PubMed ID: 6431422
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant coagulation factor VIIa in the management of bleeding in patients with von Willebrand disease type 2A.
    Matyskova M; Vorlova Z; Habart D; Martinkova I; Bulikova A; Dulicek P; Ptak J
    Transfus Apher Sci; 2004 Aug; 31(1):75-7. PubMed ID: 15294198
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome.
    Macik BG; Gabriel DA; White GC; High K; Roberts H
    Arch Pathol Lab Med; 1988 Feb; 112(2):143-6. PubMed ID: 2447856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two cases of atypical von Willebrand's disease with inhibitory effect on von Willebrand factor (author's transl)].
    Fukui H; Okuda T; Takase T; Mikami S; Yoshioka A; Fujimura Y; Yoshioka K
    Nihon Ketsueki Gakkai Zasshi; 1978 Oct; 41(5):897-907. PubMed ID: 310619
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastrointestinal angiodysplasia in a patient with type 2 von Willebrand's disease and analysis of exon 28 of the von Willebrand factor gene.
    Satoh Y; Kita H; Kihira K; Mutoh H; Osawa H; Satoh K; Ido K; Sakata Y; Sugano K
    Am J Gastroenterol; 2004 Dec; 99(12):2495-8. PubMed ID: 15571600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor.
    Mannucci PM; Tamaro G; Narchi G; Candotti G; Federici A; Altieri D; Tedesco F
    Eur J Haematol; 1987 Nov; 39(5):467-70. PubMed ID: 3121382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrasonic-exposed factor VIII and von Willebrand's disease].
    Casillas G; Simonetti C; Kempfer C
    Medicina (B Aires); 1981; 41 Suppl():253-6. PubMed ID: 6808289
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of recombinant activated factor VII in congenital and acquired von Willebrand disease.
    Franchini M; Veneri D; Lippi G
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):615-9. PubMed ID: 17102646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired von Willebrand's syndrome: a single institution experience.
    Kumar S; Pruthi RK; Nichols WL
    Am J Hematol; 2003 Apr; 72(4):243-7. PubMed ID: 12666134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient.
    Rosenfeld SB; Watkinson KK; Thompson BH; Macfarlane DE; Lentz SR
    Thromb Haemost; 2002 May; 87(5):925-6. PubMed ID: 12038803
    [No Abstract]   [Full Text] [Related]  

  • 20. [Von Willebrand disease--type 2N (case report)].
    Zarnovicanová M; Pelikánová S
    Vnitr Lek; 2003 Apr; 49(4):319-21. PubMed ID: 12793057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.